BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 16733283)

  • 21. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
    Katagiri H; Kawai Y; Sugizaki N; Sakai K; Handa M; Okamoto S; Watanabe K
    Rinsho Byori; 2003 Jun; 51(6):516-21. PubMed ID: 12884737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Willebrand factor and thrombotic thrombocytopenic purpura.
    Raife TJ; Montgomery RR
    Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Lämmle B
    Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
    Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
    Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
    Tsai HM
    J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?
    Desch K; Motto D
    J Am Soc Nephrol; 2007 Sep; 18(9):2457-60. PubMed ID: 17687074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB; Mayfield CA; Blackall DP
    Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombotic microangiopathies: towards a pathophysiology-based classification.
    Coppo P; Veyradier A
    Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe ADAMTS-13 deficiency in childhood.
    Schneppenheim R; Budde U; Hassenpflug W; Obser T
    Semin Hematol; 2004 Jan; 41(1):83-9. PubMed ID: 14727263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
    Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
    Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
    Manea M; Karpman D
    Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.